BioAge Labs Inc [BIOA] stock prices are up 2.71% to $4.93 at the moment. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The BIOA shares have gain 6.94% over the last week, with a monthly amount glided 12.05%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Morgan Stanley downgraded its rating to Underweight on December 10, 2024, and dropped its price target to $5. On December 09, 2024, downgrade downgraded it’s rating to Hold and revised its price target to $7 on the stock. Citigroup downgraded its rating to a Neutral and decreased its price target to $7 on December 09, 2024. Morgan Stanley initiated its recommendation with a Overweight and recommended $40 as its price target on October 21, 2024. Jefferies started tracking with a Buy rating for this stock on October 21, 2024, and assigned it a price target of $42. In a note dated October 21, 2024, Citigroup initiated a Buy rating and provided a target price of $45 on this stock.
The stock price of BioAge Labs Inc [BIOA] has been fluctuating between $2.88 and $26.62 over the past year. Currently, Wall Street analysts expect the stock to reach $5 within the next 12 months. BioAge Labs Inc [NASDAQ: BIOA] shares were valued at $4.93 at the most recent close of the market. An investor can expect a potential return of 1.42% based on the average BIOA price forecast.
Analyzing the BIOA fundamentals
Gross Profit Margin for this corporation currently stands at 0.98% with Operating Profit Margin at -23.64%, Pretax Profit Margin comes in at -20.46%, and Net Profit Margin reading is -20.46%. To continue investigating profitability, this company’s Return on Assets is posted at -0.25, Equity is -0.25 and Total Capital is -0.31. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.03.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 4.78 points at the first support level, and at 4.62 for the second support level. However, for the 1st resistance point, the stock is sitting at 5.09, and for the 2nd resistance point, it is at 5.25.
Ratios To Look Out For
It’s worth pointing out that BioAge Labs Inc [NASDAQ:BIOA]’s Current Ratio is 13.21. As well, the Quick Ratio is 13.21, while the Cash Ratio is 9.65. Considering the valuation of this stock, the price to sales ratio is 45.79, the price to book ratio is 0.60.
Transactions by insiders
Recent insider trading involved Barton Shane, Principal Accounting Officer, that happened on Sep 27 ’24 when 2632.0 shares were purchased. Director, Pande Vijay Satyanand completed a deal on Oct 01 ’24 to buy 0.13 million shares. Meanwhile, Director Pande Vijay Satyanand bought 67096.0 shares on Oct 02 ’24.
